Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility
Authors:
- 29 January 2007
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 39 (5) , 255-268
Abstract
In this review, we describe the current laboratory approach to quantitative chimerism testing based on short tandem repeats (STRs), focusing on a longitudinal analysis. The latter is based on relative changes appearing in the course of sequential samples, and as such exploits the ultimate potential of this intrinsically semiquantitative platform. Such an analysis is more informative than single static values, less likely to be confused with platform artifacts, and is individualized to the particular patient. It is particularly useful with non-myeloablative conditioning, where mixed chimerism is common. Importantly, longitudinal monitoring is a routinely feasible laboratory option because multiplex STR-polymerase chain reaction kits are available commercially, and modern software can be used to perform computation, reliability testing and longitudinal tracking in a rapid, easy to use format. The ChimerTrack application, a shareware, user friendly program developed for this purpose, produces a report that automatically summarizes and illustrates the quantitative temporal course of the patient's chimeric status. Such a longitudinal perspective enhances the value of quantitative chimerism monitoring for decisions regarding immunomodulatory post transplant therapy. This information also provides unique insights into the biological dynamics of engraftment underlying the fluctuations in the temporal course of a patient's chimeric status.Keywords
This publication has 41 references indexed in Scilit:
- Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningBlood, 2004
- Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survivalLeukemia, 2004
- Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old themeBone Marrow Transplantation, 2004
- Diagnostic Chimerism Analysis After Allogeneic Stem Cell TransplantationAmerican Journal of PharmacoGenomics, 2004
- Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantationBone Marrow Transplantation, 2003
- Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral bloodLeukemia, 2003
- Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situationsLeukemia, 2003
- Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemiaBone Marrow Transplantation, 1998
- Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMTBone Marrow Transplantation, 1998
- Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantationBone Marrow Transplantation, 1997